Developmental Activities:

Non-Human Clinical Studies

  • cGMP fill and finish operations for pre-filled syringes and auto-injector systems
  • Chemistry and Manufacturing Control (CMC) sections of a Drug Application
  • Identification and qualification of suppliers of device components and assemblies
  • drug solution excipients and active pharmaceutical ingredients (API)
  • Formulation development
  • Container closure system manufacturers in the selection of drug contact materials
  • ICH shelf-life studies
  • Assay method and specifications for API, excipients and final drug product
  • Identification of drug impurities
  • Toxicology studies per FDA Guidelines

MSA News

Mesa Science Associates Receives Grant to Begin Study of a Treatment for Marfan Syndrome

Mesa Science Associates Inc. (MSA) received a Phase I Small Business Innovative Research Grant (SBIR) from the National Institutes of…

Read More

NIH SBIR Grant application 1/5/2022

Mesa Science Associates has applied for an NIH Small Business Innovative Research (SBIR) Grant from the National Institutes of Health…

Read More

Mesa Green Caine Study Results Reported at Epilepsy Conference

Mesa Science Associates Inc. (MSA) and Mesa Green Pharma LLC (MGP) are pleased to announce the results of a study…

Read More